Key result
IVUS-guided PCI tests target vessel failure reduction versus angio-guidance in complex coronary lesions.
Why the study?
Does IVUS-guided PCI reduce target vessel failure compared to angiography-guided PCI in patients undergoing complex high-risk indicated procedures?
RCT (n=2,020)
randomized
Yes
Does IVUS-guided PCI reduce target vessel failure compared to angiography-guided PCI in patients undergoing complex high-risk indicated procedures?
Answers are grounded in this paper and cite their sources.
The IVUS CHIP trial will evaluate whether IVUS-guided PCI is superior to angiography-guided PCI for reducing target vessel failure in complex high-risk procedures in a European population.
BACKGROUND: Intravascular ultrasound (IVUS) guidance for percutaneous coronary intervention (PCI) has been associated with a reduction in clinical events. Whereas most evidence is generated in Asian-Pacific populations, its global adoption remains low. METHODS: The IVUS complex high-risk indicated procedures (CHIP) trial is a multicenter, international, event-driven, randomized superiority trial comparing IVUS-guided PCI with angio-guided PCI during complex high-risk indicated procedures. The primary endpoint is target vessel failure, defined as a composite of cardiac death, target vessel myocardial infarction, or clinically indicated target vessel revascularization. The IVUS CHIP trial utilizes an event-driven approach. The outcomes for the primary endpoint are first reported when at least 169 patients with a primary endpoint have been confirmed. A total of 2020 patients will be enrolled in 37 European sites. CONCLUSIONS: The aim of the IVUS CHIP trial is to assess the superiority of an IVUS-guided approach vs an angio-guided approach in patients undergoing complex high-risk indicated procedures in terms of the study primary endpoint of target vessel failure. TRIAL REGISTRATION: The IVUS CHIP trial is registered at ClinicalTrial.gov and assigned the identifier NCT04854070.
No takes yet. Share an insight, caveat, or question.
Diletti et al. (2026) conducted an RCT in Complex high-risk indicated procedures (PCI) (n=2,020). IVUS-guided PCI vs. Angio-guided PCI was evaluated on Target vessel failure, defined as a composite of cardiac death, target vessel myocardial infarction, or clinically indicated target vessel revascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: